SQI Diagnostics Inc. Responds to Change in FDA Priorities in Emergency Use Authorization
TORONTO, Oct. 19, 2021 /PRNewswire/ – SQI Diagnostics Inc. (“SQI” or the “Company”) (TSXV: SQD) (OTCQB: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics,…
